Built from the FDA label, NIH LiverTox and MedlinePlus lab guides. Current as of October 2026. Use it to prepare for conversations with your care team, not to interpret your results on your own.
Day 14 of your first albendazole cycle. The patient portal pings with new lab results, and a row of numbers appears with one or two of them flagged “H.” Your ALT is above the reference range. Your doctor’s office has not called yet. Do you stop the pills? Is your liver failing? Was it the drink you had last weekend?
Take a breath. Rising liver enzymes are one of the most expected findings during longer albendazole treatment, which is exactly why blood tests are scheduled in the first place. Understanding albendazole and liver health starts with knowing what the label says, what each number on your panel represents, and what your doctor is likely to do next. This guide is a lab-report decoder: it walks you through your liver panel line by line, lays out a monitoring timeline, and ends with a checklist to bring to your next appointment.
Key point: A flagged enzyme is a signal for your doctor to review, not a signal for you to stop treatment on your own. Call the office, describe any symptoms, and let them decide.
What the label says about albendazole and liver health
Albendazole (brand name Albenza in the US) is approved by the FDA for two serious tapeworm-larvae infections: cystic hydatid disease of the liver, lung and abdominal lining, and parenchymal neurocysticercosis, where cysts sit in the brain. Both require weeks of treatment, often at 400 mg twice a day with meals, or a weight-based dose for people under 60 kg. That longer, higher-exposure treatment is where liver effects show up. If you are new to the drug, our overview of what albendazole is explains its uses.
Here is what the FDA prescribing information reports.
How often enzymes rise
| Finding in clinical trials | Hydatid disease | Neurocysticercosis |
|---|---|---|
| Elevated liver enzymes | 16% | Less than 1% |
| Abdominal pain | 6% | 0% |
| Nausea / vomiting | 4% / 4% | 6% / 6% |
| Stopped treatment for liver abnormalities | 3.8% | Not reported as a main reason |
The label describes most of these enzyme rises as mild to moderate and says they generally went back to normal after treatment stopped. Why the big gap between the two conditions? Hydatid treatment usually runs longer, in repeated 28-day cycles, and the cysts themselves often live in the liver. Neurocysticercosis courses are shorter, typically 8 to 30 days per the label.
Monitoring requirements
- Liver enzymes (transaminases) should be checked before the start of each 28-day cycle and at least every two weeks during treatment.
- If enzymes climb above twice the upper limit of normal, the label says stopping treatment may be considered, based on the individual patient.
- Treatment should be discontinued if enzymes are significantly increased.
- Restarting after enzymes return to pretreatment levels is a case-by-case decision, with frequent lab checks if therapy resumes.
- Blood counts are checked on the same schedule because of a separate warning about bone marrow suppression.
Hepatitis and liver failure
The label also mentions case reports of hepatitis and acute liver failure, including postmarketing reports, though it notes that a causal link was not always certain. These are rare, but they are the reason the monitoring schedule exists.
Understanding your liver panel
A “liver function test” or “liver panel” is a group of blood tests. According to MedlinePlus’s liver function test guide, these tests can show how well the liver is working and whether it may be damaged, but they usually cannot pinpoint a specific disease alone. Doctors look at the pattern across all of them.
We have deliberately not listed numeric “normal” ranges. Ranges vary by laboratory, age and sex, and your report prints the lab’s own range next to each result. Compare your number to that line, and ask your clinician what it means for you.
| Test | What it measures | How to read the reference range | What a change could mean on albendazole |
|---|---|---|---|
| ALT (alanine transaminase) | An enzyme found mainly in liver cells. Damaged cells release it into the blood. | Your lab lists an upper limit. Doctors often describe rises as “times the upper limit of normal.” | The most common marker to rise during long courses. A mild rise is often transient; a larger rise may prompt a pause. |
| AST (aspartate aminotransferase) | An enzyme in the liver and also in muscle and other tissues. | Read alongside ALT; the two often move together in liver cell injury. | Usually rises with ALT. Hard exercise can also raise AST, so mention any intense workouts. |
| ALP (alkaline phosphatase) | An enzyme from the liver and bile ducts, and also from bone. | Higher values may reflect bile duct or bone sources. | A rise may point toward bile flow problems, which matter with liver cysts or bile duct blockage. |
| Bilirubin | A yellow waste product from old red blood cells, cleared by the liver. | Reported as total and sometimes direct (conjugated) bilirubin. | Rising bilirubin, especially with jaundice, suggests the liver or bile ducts are struggling and needs prompt attention. |
| Albumin | A protein made by the liver. | Low values can reflect reduced liver production over time, or nutrition and kidney factors. | Usually stable during a short drug reaction; a drop may reflect longer-standing liver disease. |
| GGT (if included) | A liver enzyme linked to bile ducts. | Helps tell whether a high ALP comes from liver or bone. | Can also rise with alcohol use, which is one reason to avoid drinking before tests. |
| PT/INR (if included) | How long blood takes to clot, using proteins made by the liver. | A longer time can mean reduced liver function. | A rise alongside high enzymes or bilirubin is more serious than an enzyme rise alone. |
MedlinePlus’s ALT test page lists many possible causes of a high ALT, from hepatitis and fatty liver to certain medicines and intense exercise, and points out that a high reading does not always mean a condition that needs treatment. That is why your doctor looks at the trend from test to test rather than a single result.
Reading the pattern
- ALT and AST up, bilirubin normal: the most typical picture of a mild drug effect on liver cells.
- ALP and GGT up more than ALT: suggests a bile-flow (cholestatic) pattern, which may relate to cysts or bile duct issues as well as the drug.
- Enzymes up plus rising bilirubin or INR: a red flag pattern that usually triggers urgent review.
The other report that arrives with it: your blood count
Your liver panel usually lands next to a complete blood count (CBC), and the two are linked when you think about albendazole and liver health. The FDA label warns that albendazole can suppress the bone marrow, with rare fatal cases of very low white cells (granulocytopenia) or of all blood cell types (pancytopenia). The label also notes that people with liver disease, including liver hydatid cysts, are more vulnerable to this effect. So if your ALT is up, your doctor will look just as hard at your white blood cell count, neutrophils, hemoglobin and platelets.
- White blood cells and neutrophils: your infection fighters. A drop raises infection risk; sore throat and fever matter more when these are low.
- Hemoglobin: carries oxygen. A fall can cause tiredness, pale skin and shortness of breath.
- Platelets: help blood clot. Low levels can mean easy bruising, nosebleeds or bleeding gums.
The label says treatment should stop if blood counts drop in a clinically significant way. As with liver enzymes, that decision belongs to your prescriber.
Before your blood draw
MedlinePlus notes that you may be asked to fast for 10 to 12 hours before a liver panel, and that you should tell your provider about every medicine you take, since some affect results. Don’t stop any medicine before the test unless told to. Results can also be thrown off briefly by a recent viral illness, which is one reason a single odd number is often simply repeated.
Who’s at higher risk
Several groups need closer watching during albendazole therapy.
People with existing liver disease
The liver converts albendazole into albendazole sulfoxide, the active form that reaches cysts in tissue. When the liver or bile system is not working well, that conversion and clearance can change. The FDA label specifically warns that patients with liver disease, including hepatic echinococcosis (hydatid cysts in the liver), face a higher risk of bone marrow suppression and need more frequent blood count checks.
People with bile duct obstruction
In a small group of five patients with extrahepatic biliary obstruction, the label reports that sulfoxide exposure rose sharply: about a twofold higher peak and roughly sevenfold higher overall exposure compared with healthy people, with a much longer half-life (around 32 hours on average). More drug lingering in the body means more potential for side effects, including on the liver.
People with hydatid cysts in the liver
Liver cysts can press on bile ducts, cause inflammation, or rupture. Baseline liver tests may already be abnormal before the first pill. Your doctor will compare later results against your own starting point, not just the lab range. If cysts are being treated alongside surgery or drainage, enzyme changes may also reflect those procedures.
Other factors that add risk
- Regular or heavy alcohol use, covered in detail in our guide to albendazole and alcohol.
- Viral hepatitis B or C, fatty liver disease, or prior drug-induced liver injury.
- A past reaction to albendazole or mebendazole. LiverTox reports that injury often returns on rechallenge.
- Combination therapy. Dexamethasone and praziquantel each raised albendazole sulfoxide levels in label studies (about 56% and 50% respectively). This is common in neurocysticercosis treatment.
- Repeated courses, which LiverTox notes can bring on injury sooner.
Monitoring timeline for a 28-day cycle
The label’s schedule for hydatid disease is three 28-day cycles, each followed by a 14-day break. Here is how monitoring typically maps onto one cycle. Your doctor may add tests, especially if you have risk factors or early abnormal results.
| When | What is usually checked | Why | Your job |
|---|---|---|---|
| Before day 1 | Liver panel, complete blood count; pregnancy test if applicable | Sets your personal baseline; label calls for testing before each cycle | List all medicines and supplements; mention any liver history |
| Day 1 | Start albendazole with meals | Food boosts absorption for tissue infections | Set dose reminders; see our guide on taking albendazole with food |
| Around day 14 | Liver panel and blood count | Label: at least every 2 weeks during therapy | Avoid alcohol and unusual heavy exercise in the days before the draw |
| Around day 28 (end of cycle) | Liver panel and blood count | Catches changes from the second half of the cycle | Report any symptoms, even mild ones |
| Days 29–42 (drug-free break) | Often no routine test unless results were abnormal | Gives the liver and bone marrow a recovery window | Keep avoiding alcohol unless your doctor says otherwise |
| Before next cycle | Liver panel and blood count again | Confirms it is safe to restart | Do not start cycle two until your doctor reviews the results |
For shorter neurocysticercosis courses, the same principle applies: baseline tests, then at least every two weeks while you are on the drug. Single-dose or three-day treatments for gut worms usually do not need routine liver tests in healthy people.
Keeping your own results log
Patient portals often show one result at a time, which makes trends hard to see. A simple notebook or phone note with five columns (date, ALT, AST, ALP, bilirubin) plus a line for symptoms turns a confusing pile of reports into a clear picture. When your doctor asks “how have you been doing?”, you can show the trend in seconds. It also helps if you change clinics, travel, or see a specialist who does not have access to your earlier labs. Add the cycle day for each test so everyone can see where in treatment a change appeared.
Symptoms of liver trouble
Most enzyme rises on albendazole cause no symptoms at all, which is why blood tests matter more than how you feel. But call your prescriber promptly if you notice any of these:
- Yellowing of the skin or whites of the eyes (jaundice)
- Dark urine, pale or clay-colored stools
- Pain, fullness or tenderness in the upper right belly
- Nausea, vomiting or loss of appetite that is new or worsening
- Unusual tiredness or weakness
- Itchy skin without a rash
- Fever, rash or swollen glands, which LiverTox notes can accompany a hypersensitivity-type liver injury
Some of these overlap with ordinary side effects such as nausea and belly pain. Our full rundown of albendazole side effects helps separate the routine from the worrying. Go to an emergency department or call 911 for confusion, extreme sleepiness, vomiting blood, or deep jaundice with feeling very unwell.
Quick questions patients ask
Does albendazole damage the liver permanently?
In most people, no. The FDA label and LiverTox both describe enzyme rises that usually resolve after stopping the drug. Severe and lasting injury is rare, but it has been reported, which is why monitoring continues through the full course.
Can a single albendazole tablet hurt my liver?
It is uncommon. LiverTox notes that single 400 mg doses for minor worm infections are linked to liver injury mainly in isolated case reports, and that when injury follows a short course, it can appear one to two weeks later.
Can I take albendazole if I have fatty liver or hepatitis?
Often yes, but your doctor will want baseline tests and likely closer monitoring. The label flags liver disease as a reason for more frequent blood count checks. Never hide a liver diagnosis from your prescriber.
Should I take a liver supplement to protect myself?
Not without asking. Many herbal and dietary supplements are themselves listed in LiverTox as possible causes of liver injury, and they can make enzyme results harder to interpret. Talk to your doctor before adding anything.
Protecting your liver during albendazole treatment
You cannot control how your liver responds to albendazole, but you can remove avoidable extra load.
Alcohol
The albendazole label does not list a formal alcohol interaction, but alcohol is processed by the liver and can raise enzymes such as GGT. During long courses, most clinicians advise avoiding it entirely, including in the days before each blood draw so results reflect the drug and not the weekend.
Acetaminophen and other pain relievers
Acetaminophen (Tylenol) is a common choice for headaches during treatment, but in large amounts it can harm the liver, and the NIAAA alcohol-medicine interaction chart lists liver damage as a risk when it is combined with alcohol. Ask your doctor what daily limit is appropriate for you while on albendazole, and check cold and flu products, which often contain hidden acetaminophen. Do not switch to other pain relievers without checking either, since some have their own stomach or kidney risks.
Supplements and herbal products
Green tea extract, high-dose turmeric products, kava, certain bodybuilding supplements and many multi-ingredient “detox” blends appear in liver injury reports. Bring every bottle you take to your first appointment, or a photo of each label.
Other everyday steps
- Keep every lab appointment, even if you feel fine.
- Take albendazole exactly as prescribed; do not double doses.
- Tell any new doctor, dentist or pharmacist that you are on albendazole.
- Ask whether hepatitis A and B vaccines are recommended for you, if you are not already protected.
- Eat regular meals, stay hydrated, and avoid crash diets during treatment.
What happens if enzymes rise
Back to our opening scene: your day-14 ALT is flagged high. Here is roughly how doctors work through it, though each case is individual.
- Compare to baseline. Is this a new rise, or were your levels already high from liver cysts or another condition?
- Check the size of the rise. The label uses twice the upper limit of normal as a point where stopping may be considered. A small bump below that may simply mean repeat testing sooner.
- Look at the rest of the panel. Bilirubin, INR and blood counts help decide how serious it is.
- Ask about symptoms and other causes. Alcohol, new medicines, supplements, viral illness or intense exercise can all affect results.
- Decide: continue, pause or stop. Options include continuing with closer monitoring, pausing until levels settle, or stopping. The label says restarting after normalization is an individual decision with frequent testing.
- Consider alternatives if needed. LiverTox notes that switching to another benzimidazole calls for caution and close monitoring, and moving to a different drug class may be safer if treatment must continue. For hydatid disease, surgery or drainage may also come into the picture; our guide to albendazole for tapeworm describes the broader treatment options.
The one thing you should not do is stop or restart the drug on your own. Stopping too early can leave live cysts behind; continuing through a serious reaction can be harmful. That is your prescriber’s call.
The LiverTox entry, summarized
LiverTox is a free reference from the National Institutes of Health that clinicians use to judge whether a drug may be harming the liver. Its albendazole entry, last updated in April 2026, covers the following points in plain terms:
| Topic | What LiverTox reports |
|---|---|
| How common | Temporary, symptom-free enzyme rises in up to 50% of patients treated for more than a few weeks; about 4% needed to stop |
| Likelihood score | B: highly likely cause of clinically apparent liver injury |
| Timing | Usually within a few days to about two months of starting; sooner with repeat courses; 1–2 weeks after a 1–3 day course |
| Likely mechanism | Most clinically apparent cases appear to be hypersensitivity (immune) reactions |
| Usual outcome | Mostly mild to moderate with quick recovery after stopping; rare severe cases, including acute liver failure |
| Rechallenge | Recurrence is common, often with similar severity; re-exposure should be avoided after liver injury |
| Monitoring advice | Check enzymes before therapy and every 2 weeks during extended courses |
Put simply, LiverTox and the FDA label tell the same story: liver effects are common on long courses, usually mild, occasionally serious, and best managed by regular testing.
Bring this to your next appointment
Print or screenshot this list. It turns a rushed visit into a useful one.
- Your baseline and most recent liver panel results, side by side
- Your blood count results from the same dates
- A full list of medicines, supplements, herbal teas and over-the-counter products
- How much alcohol you have had since starting treatment, honestly
- Any symptoms, with dates: nausea, belly pain, dark urine, itching, yellow eyes, fever or rash
- Your liver history: hepatitis, fatty liver, gallstones, bile duct problems, or a past reaction to albendazole or mebendazole
- Questions to ask:
“Which of my results are outside range, and by how much?”
“Is this a pause, stop, or keep-going situation?”
“When is my next blood test?”
“What daily acetaminophen limit is safe for me right now?”
“Which symptoms should make me call before my next test?” - Your cycle calendar, so you and your doctor agree on where you are in treatment
If anyone in your household accidentally takes your albendazole or too much acetaminophen, call Poison Control at 1-800-222-1222.
